Cwm LLC Boosts Stock Holdings in Astera Labs, Inc. $ALAB

Key Points

• Cwm LLC has increased its stake in Astera Labs, Inc. by 79.3% in the second quarter, now owning 6,734 shares valued at approximately $609,000.
• Numerous large investors have boosted their holdings in Astera Labs, including Alliancebernstein L.P., which raised its stake by 114.2% in the first quarter.
• The company reported a significant 149.5% year-over-year revenue increase with $191.93 million in revenue and an earnings per share (EPS) of $0.44, beating analyst expectations.

Cwm LLC increased its position in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 79.3% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 6,734 shares of the company's stock after purchasing an additional 2,979 shares during the period. Cwm LLC's holdings in Astera Labs were worth $609,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in ALAB. Alliancebernstein L.P. raised its holdings in Astera Labs by 114.2% during the first quarter. Alliancebernstein L.P. now owns 8,401,019 shares of the company's stock worth $501,289,000 after purchasing an additional 4,478,741 shares in the last quarter. Atreides Management LP increased its holdings in Astera Labs by 153.3% in the first quarter. Atreides Management LP now owns 4,652,264 shares of the company's stock valued at $277,601,000 after buying an additional 2,815,614 shares in the last quarter. FengHe Fund Management Pte. Ltd. purchased a new position in Astera Labs in the second quarter valued at about $106,772,000. Bank of Nova Scotia increased its holdings in Astera Labs by 3,742.2% in the first quarter. Bank of Nova Scotia now owns 964,400 shares of the company's stock valued at $57,546,000 after buying an additional 939,300 shares in the last quarter. Finally, Jump Financial LLC purchased a new position in Astera Labs in the first quarter valued at about $32,998,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, General Counsel Philip Mazzara sold 10,000 shares of the firm's stock in a transaction that occurred on Wednesday, October 1st. The shares were sold at an average price of $192.16, for a total transaction of $1,921,600.00. Following the sale, the general counsel owned 151,573 shares in the company, valued at approximately $29,126,267.68. This trade represents a 6.19% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Jitendra Mohan sold 91,441 shares of the firm's stock in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $183.51, for a total transaction of $16,780,337.91. Following the sale, the chief executive officer owned 2,170,877 shares in the company, valued at approximately $398,377,638.27. This trade represents a 4.04% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 1,092,997 shares of company stock valued at $192,231,120 in the last 90 days. Insiders own 12.50% of the company's stock.

Analyst Upgrades and Downgrades

ALAB has been the subject of a number of research analyst reports. Zacks Research cut shares of Astera Labs from a "strong-buy" rating to a "hold" rating in a report on Monday, October 6th. Susquehanna increased their target price on shares of Astera Labs from $80.00 to $125.00 and gave the company a "neutral" rating in a report on Thursday, August 7th. Stifel Nicolaus increased their target price on shares of Astera Labs from $174.00 to $185.00 and gave the company a "buy" rating in a report on Friday, October 17th. Northland Securities lowered shares of Astera Labs from an "outperform" rating to a "market perform" rating and set a $120.00 price target on the stock. in a research report on Tuesday, July 22nd. Finally, Needham & Company LLC increased their price target on shares of Astera Labs from $100.00 to $170.00 and gave the company a "buy" rating in a research report on Wednesday, August 6th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat.com, Astera Labs presently has a consensus rating of "Moderate Buy" and a consensus target price of $162.06.

Astera Labs Price Performance

ALAB stock opened at $163.64 on Friday. The company's 50 day simple moving average is $197.21 and its 200-day simple moving average is $130.64. The firm has a market capitalization of $27.20 billion, a PE ratio of 292.21, a P/E/G ratio of 3.86 and a beta of 1.43. Astera Labs, Inc. has a 12 month low of $47.13 and a 12 month high of $262.90.

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, beating the consensus estimate of $0.33 by $0.11. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The business had revenue of $191.93 million for the quarter, compared to analyst estimates of $172.46 million. During the same period in the prior year, the business earned $0.13 earnings per share. The company's quarterly revenue was up 149.5% on a year-over-year basis. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. As a group, sell-side analysts anticipate that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.